跳至主要内容
临床试验/ACTRN12616000366459
ACTRN12616000366459已完成3 期

A pilot study of gabapentin for managing pain in children with dystonic cerebral palsy

Murdoch Childrens Research Institute0 个研究点目标入组 13 人开始时间: 2016年3月22日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
13

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
6 Years 至 18 Years(—)
性别
All

入选标准

  • 1)Confirmation of dystonia after completion of the Hypertonicity Assessment Tool (HAT). Those children who have dystonia or a mixed diagnosis (spasticity and dystonia) will be eligible.
  • 2)Severity of dystonia will be determined with the Barry Albright Dystonia (BAD) scale. Children with a score of 15 or higher on the BAD scale will be eligible.
  • 3)Pain will be quantified using the Health Utilities Index 3 (HUI 3). Those children scoring IV or V will be eligible.

排除标准

  • Children excluded from the study will be those who:
  • 1.Are younger than 6 years because they will have more difficulty with reliably self-reporting and will not be able to perform some of the quantitative measurements.
  • 2.Are currently on gabapentin or have been on gabapentin in the previous 3 months
  • 3.Have demonstrated hypersensitivity to gabapentin or the inactive ingredients in the capsules in the past
  • 4.Are currently taking other medications that may interact with gabapentin (i.e. antacid, cimetidine, morphine, and opioids).
  • 5.Pregnant female participants

研究者

相似试验